Cargando…

A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency

SARS-CoV-2, primarily considered a respiratory virus, is increasingly recognized as having gastrointestinal aspects based on its presence in the gastrointestinal (GI) tract and feces. SARS-CoV-2 uses as a receptor angiotensin-converting enzyme 2 (ACE-2), a critical member of the renin-angiotensin-al...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sajdel-Sulkowska, Elizabeth M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226136/ https://www.ncbi.nlm.nih.gov/pubmed/34177593 http://dx.doi.org/10.3389/fphar.2021.684610

Ejemplares similares

Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling
por: Sajdel-Sulkowska, Elizabeth M.
Publicado: (2021)

The Impact of Maternal Gut Microbiota during Pregnancy on Fetal Gut–Brain Axis Development and Life-Long Health Outcomes
por: Sajdel-Sulkowska, Elizabeth M.
Publicado: (2023)

Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics
por: Basit, Abdul, et al.
Publicado: (2021)

Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice
por: Brooks, Steven D., et al.
Publicado: (2022)

Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches
por: Zareei, Sara, et al.
Publicado: (2022)

1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection
por: Chen, Rui Hong, et al.
Publicado: (2021)

Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2
por: Chen, Xi, et al.
Publicado: (2022)

NRICM101 ameliorates SARS-CoV-2–S1-induced pulmonary injury in K18-hACE2 mice model
por: Wei, Wen-Chi, et al.
Publicado: (2023)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Okoloko, Oghenemega, et al.
Publicado: (2021)

Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies
por: Suresh, Voddu, et al.
Publicado: (2021)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
por: Tyrankiewicz, Urszula, et al.
Publicado: (2021)

Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells
por: Lodi, Giada, et al.
Publicado: (2022)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
por: Saponaro, Federica, et al.
Publicado: (2020)

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
por: Verdecchia, Paolo, et al.
Publicado: (2020)

Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Simko, Fedor, et al.
Publicado: (2022)

3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor
por: Liang, Taizhen, et al.
Publicado: (2021)

Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2 Protein-Protein Interaction–a Mechanism that can Contribute to its Antiviral Activity Against COVID-19
por: Bojadzic, Damir, et al.
Publicado: (2021)

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
por: Mehdipour, Ahmad Reza, et al.
Publicado: (2021)

A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex—An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface
por: Nichols, Charlie, et al.
Publicado: (2020)

Gut ACE2 Expression, Tryptophan Deficiency, and Inflammatory Responses The Potential Connection That Should Not Be Ignored During SARS-CoV-2 Infection
por: Qin, W.-H., et al.
Publicado: (2021)

Phytochemicals as Potential Therapeutics for SARS-CoV-2–Induced Cardiovascular Complications: Thrombosis and Platelet Perspective
por: Beura, Samir K., et al.
Publicado: (2021)

The Possible Dual Role of the ACE2 Receptor in Asthma and Coronavirus (SARS-CoV2) Infection
por: Branco, Anna Cláudia Calvielli Castelo, et al.
Publicado: (2020)

Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route
por: de Oliveira, Ana Patrícia, et al.
Publicado: (2020)

Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage
por: Kirtipal, Nikhil, et al.
Publicado: (2022)

ACE2 Expression in Organotypic Human Airway Epithelial Cultures and Airway Biopsies
por: Chen, Qianyu, et al.
Publicado: (2022)

Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
por: Burgueño, Juan F, et al.
Publicado: (2020)

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
por: Song, Fucheng, et al.
Publicado: (2023)

Common Genetic Variants Link the Abnormalities in the Gut-Brain Axis in Prematurity and Autism
por: Sajdel-Sulkowska, Elżbieta M., et al.
Publicado: (2018)

Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis
por: Maremanda, Krishna P., et al.
Publicado: (2020)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2
por: Clayton, Daniel, et al.
Publicado: (2015)

Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells
por: Ahmadi Badi, Sara, et al.
Publicado: (2022)

Inherited and acquired vitamin B12 deficiencies: Which administration route to choose for supplementation?
por: Elangovan, Ramyia, et al.
Publicado: (2022)

Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
por: Yan, Meichen, et al.
Publicado: (2021)

A Novel Modulator of the Renin–Angiotensin System, Benzoylaconitine, Attenuates Hypertension by Targeting ACE/ACE2 in Enhancing Vasodilation and Alleviating Vascular Inflammation
por: Zhang, Qi-Qiang, et al.
Publicado: (2022)

Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness
por: Faisal, H.M. Nasrullah, et al.
Publicado: (2021)

Tripartite communication in COVID-19 infection: SARS-CoV-2 pathogenesis, gut microbiota and ACE2
por: Badi, Sara Ahmadi, et al.
Publicado: (2022)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
por: Verma, Surjeet, et al.
Publicado: (2020)

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later
por: Angeli, Fabio, et al.
Publicado: (2021)

Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling
por: Balkrishna, Acharya, et al.
Publicado: (2022)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mbbl7su9f2j8p0o1nh6qknjt26